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Expansion of polyglutamine (polyQ) tracts in proteins results in protein aggregation and is associated with cell death in
at least nine neurodegenerative diseases. Disease age of onset is correlated with the polyQ insert length above a
critical value of 35–40 glutamines. The aggregation kinetics of isolated polyQ peptides in vitro also shows a similar
critical-length dependence. While recent experimental work has provided considerable insights into polyQ
aggregation, the molecular mechanism of aggregation is not well understood. Here, using computer simulations of
isolated polyQ peptides, we show that a mechanism of aggregation is the conformational transition in a single polyQ
peptide chain from random coil to a parallel b-helix. This transition occurs selectively in peptides longer than 37
glutamines. In the b-helices observed in simulations, all residues adopt b-strand backbone dihedral angles, and the
polypeptide chain coils around a central helical axis with 18.5 6 2 residues per turn. We also find that mutant polyQ
peptides with proline-glycine inserts show formation of antiparallel b-hairpins in their ground state, in agreement with
experiments. The lower stability of mutant b-helices explains their lower aggregation rates compared to wild type. Our
results provide a molecular mechanism for polyQ-mediated aggregation.
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Introduction
The appearance of polyglutamine (polyQ)-containing
aggregates [1–3] is a hallmark of disease progression in all
diseases in which CAG-expansions occur in genes [2]. Intra-
nuclear inclusion bodies containing polyQ aggregates have
been found in vitro [4,5], in cell cultures, animal models, and
affected patients [6,7]. The aggregates are known to have a
characteristic amyloid topology [8]. The inhibition of
oligomerization by the azo-dye Congo red, or by the Hsp70/
Hsp40 chaperone system, exerts marked protective effects in
vivo and in vitro [9,10]. Aggregation and disease are observed
if the number of glutamines in the expansion, n, exceeds a
critical value, nC (i.e., nC ¼ 35–40) [3]. The nearly universal
existence of this criticality in all polyQ-related diseases
(except in spinocerebellar ataxia 6) suggests that when the
polyQ insert length exceeds a critical value (n . nC), a
pathological change, largely independent of the host protein,
occurs in the polyQ insert itself. Therefore, isolated polyQ
peptides (Qn) have been used as model systems for studying
polyQ aggregation [4,11,12], and it is known that: (a) The
nuclear uptake of polyQ peptide aggregates prepared in vitro
is cytotoxic in cell cultures [13], (b) isolated polyQ peptides
have in vitro aggregation properties similar to the corre-
sponding full-length proteins containing the polyQ insert
[4,14], (c) peptide aggregation follows a nucleated mechanism
showing characteristic lag and growth phases [5,11], and (d)
the glutamine tract-length dependence of the lag-time
interval correlates well with the age of onset of disease [11].
Peptides of subcritical lengths (n , 35–40) have long lag times
of aggregation and a corresponding (predicted) age of onset
later than the typical life span of a person. Longer peptides (n
. 35–40) have progressively smaller lag times of aggregation,
and a correspondingly early age of onset of the disease [11].
Unaggregated polyQ peptides form random coil structures,
whereas aggregates are composed of amyloid-like b-strands
[15]. The conversion of random coil to b-strand occurs in an
individual polyQ chain [11], and ﬁbril formation occurs by
addition of other polyQ chains to these monomeric b-strand
nuclei. Therefore, the conformational dynamics of an
individual polyQ chain determines both its aggregation
mechanism and the structure of the ﬁnal aggregates. The
details of the conformational dynamics of polyQ and the
length dependence of the dynamics are not well understood
[6].
Results/Discussion
To elucidate the structural dynamics of single polyQ
chains, we performed molecular dynamics (MD) simulations
of simpliﬁed models of polyQ. An atomic-level representa-
tion of polyQ limits sampling efﬁciency in simulations,
making it unsuitable to study the dynamics of aggregation.
Therefore, we used a simpliﬁed pseudo-atom representation
to capture the relevant degrees of freedom for aggregation.
We introduced three types of nonbonded interactions
between the glutamine pseudo-atoms: hydrophobic interac-
tions between the glutamine methylene groups, geometrically
determined hydrogen bonds between backbone NH and O
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the sidechain carboxylamine group and the backbone NH or
O atoms. Protein-solvent interactions play an important role
in protein folding and aggregation. However, in simpliﬁed
models of protein folding and aggregation the solvent
interactions are considered implicitly [16]. In the interaction
models employed in our study, the solvent effects were
captured by the effective hydrophobic interactions between
the methylene groups in the sidechain. We used the discrete
molecular dynamics (DMD) algorithm [17] to study polyQ
dynamics.
The ﬁrst question that we address is the following: What is
the underlying minimal set of interactions responsible for the
experimentally observed conformational transitions in polyQ
aggregation? Since the conformational transition from
random-coil polyQ to b-strand is known to be a nucleated
process [11], we expect that an energy barrier is crossed
during b-strand formation. Barrier crossing is enhanced as
the system temperature is increased. Therefore, we study the
dynamics of model polyQ peptides as a function of temper-
ature. We hypothesized that the physical basis of the
conformational change from random coil to b-strands is the
presence of unique sidechain-backbone hydrogen bonding
interactions in polyQ. To test this hypothesis, we performed
simulations of a 37-mer (Q37) polyQ peptide with and without
sidechain-backbone hydrogen bonding interactions. It is
known that homopolymeric peptides with no sidechain-
backbone interactions, e.g., polyalanine, form a-helices in
their ground state [18,19], and at higher temperatures the
helices melt to form a random coil [20] that then aggregates
into a b-rich structure. We found that in the absence of
sidechain-backbone interactions, polyQ dynamics are similar
to polyalanine: It forms a-helices at low temperature (Figure
1A), and a random coil as the temperature is increased. A
monomer peptide in this polyQ model does not form b-
strands. In contrast, when sidechain-backbone hydrogen
bonding is present, polyQ is a random coil at low temper-
atures, adopts a b-strand conformation in an intermediate
range of temperatures, and is again a random coil at higher
temperatures (Figure 1B).Thus, sidechain-backbone interac-
tions lead to the formation of b-strands by a single polyQ
peptide, which is the nucleating structural transition
observed in polyQ-peptide aggregation.
Strikingly, the conformation adopted by a Q37 chain under
conditions in which it adopts b-strand topologies (T¼0.72 to
T ¼ 0.78, in units of e/kB, where e is the energy unit and kB is
the Boltzmann’s constant) is a parallel b-helix (Figure 1C). In
these b-helices, all residues adopt b-strand backbone dihedral
angles, and the polypeptide chain coils around a central
helical axis. Several examples of such parallel b-helices
(reviewed by Wetzel [21]) are found in the Protein Databank
(http://www.rcsb.org/pdb/). For amyloid ﬁbrils formed by
polyQ, Perutz previously proposed a b-helix model based
on X-ray diffraction data [8]. However, in contrast with
Perutz’s model, which has a central aqueous pore, the b-
helices observed in our simulations are well packed, exclude
the solvent, and are stabilized by buried sidechain-backbone
and sidechain-sidechain hydrogen bonds (Figure 1D–1F). To
evaluate whether these b-helix structures, once formed, have
residence times long enough to propagate further aggrega-
tion, and to obtain better-deﬁned thermodynamic ensembles,
we evaluated the stability of b-helices at 300 Kelvin using all-
atom MD simulations. As shown in Figure 2A, the polyQ
structure remains stable on the nanosecond time scale
accessible in all-atom simulations. If the formation of b-
helices corresponds to the nucleation step in the aggregation
reaction [5], and, assuming that the further elongation of the
aggregate is diffusion-limited, the average time between
protein collisions at a concentration of 100 lM is expected
to be about 10 ns. Therefore, the observed stability of the
polyQ b-helix on the nanosecond time scale is expected to be
sufﬁcient for further propagation of the aggregate.
Apart from sidechain-backbone interactions, a number of
sidechain-sidechain interactions persisted throughout the
MD simulation. We did not use sidechain-sidechain hydrogen
bonding interactions in the DMD simulations used to
generate b-helices. Thus, even though sidechain-sidechain
interactions were not required for the formation of b-helices,
they were nevertheless formed in b-helices. Further, these
interactions were persistent throughout the length of the all-
atom MD simulations, suggesting that they do play a
signiﬁcant role in the stabilization of the b-helices.
By characterizing the length dependence of b-helix
formation, we uncovered the molecular basis of the observed
glutamine length dependence of polyQ aggregation. Since the
average number of residues per turn of the b-helix in our
simulations is 18.5 6 2 residues, we expected that about 33–
40 glutamines would be required for its formation. To test
this hypothesized length dependence of b-helix formation, we
studied the conformational dynamics of 25-mer and 45-mer
polyQ peptides and found that b-helices are absent at all
temperatures when the repeat length was 25. Moreover, the b-
helix topology was stable in a broader range of temperatures
for the 45-mer (Figure 2B), demonstrating that b-helix
formation increases with the length of polyQ. The formation
of a b-helix from a random coil was accompanied by entropy
loss, leading to a free energy barrier. This barrier results in
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Synopsis
Nine human diseases, including Huntington’s disease, are associated
with an expanded trinucleotide sequence CAG in genes. Since CAG
codes for the amino acid glutamine, these disorders are collectively
known as polyglutamine diseases. Although the genes (and
proteins) involved in different polyglutamine diseases have little in
common, the disorders they cause follow a strikingly similar course:
If the length of the expansion exceeds a critical value of 35–40, the
greater the number of glutamine repeats in a protein, the earlier the
onset of disease and the more severe the symptoms. This fact
suggests that abnormally long glutamine tracts render their host
protein toxic to nerve cells, and all polyglutamine diseases are
hypothesized to progress via common molecular mechanisms. One
possible mechanism of cell death is that the abnormally long
sequence of glutamines acquires a shape that prevents the host
protein from folding into its proper shape. What is the structure
acquired by polyglutamine and what is the molecular basis of the
observed threshold repeat length? Using computer models of
polyglutamine, the authors show that if, and only if, the length of
polyglutamine repeats is longer than the critical value found in
disease, it acquires a specific shape called a b-helix. The longer the
glutamine tract length, the higher is the propensity to form b-
helices. This length-dependent formation of b-helices by polyglut-
amine stretches may provide a unified molecular framework for
understanding the structural basis of different trinucleotide repeat-
associated diseases.the lag times observed in experiments of polyQ peptide
aggregation [11]. Barrier crossing is enhanced for longer
peptides, because the enthalpy gain upon b-helix formation
compensates for the entropy loss in the transition. Therefore,
b-helices are formed only by peptides longer than a critical
length (n . nC). Recently, Stork et al. [22] found that the
dimerization of two Q37 b-helices resulted in a stabilization of
the (preformed, in their study) b-helix conformation. The
stabilization of the b-helix upon dimerization shows that the
dimerization is a downhill process (i.e., there is no energy
barrier) on the free-energy landscape. Thus, we propose that
length-dependent b-helix formation may be the molecular
origin of polyglutamine-mediated aggregation. We also
propose that once a b-helix is formed by a monomer, the
elongation of the aggregate may involve the conversion of
other chains to b-helices induced by the b-helix nucleus. A
ﬁbril may be formed by stacking of multiple b-helices, as
suggested by Stork et al. [22], and these ﬁbrils may arrange
further to form larger ﬁbers.
The formation of b-helices by a single polyQ chain can be
used to rationalize the aggregation of experimentally
characterized mutant polyQ peptides. Previously, Thakur
Figure 1. Dynamics of PolyQ Peptides
(A, B) The fraction of secondary structure as a function of temperature for model polyQ peptides (A) without sidechain-backbone interactions, and (B)
with sidechain-backbone interactions. Only helices and b-strands are shown; at each temperature the remainder is random coil.
(C) A b-helix formed by a Q37 at the temperature T ¼ 0.74. The width of the helix is 12–13 A ˚, and the distance between strands is 4–5 A ˚.
(D) The network of possible sidechain-backbone (green) and sidechain-sidechain (orange) hydrogen bonding interactions in the core of the b-helix.
Hydrogen bonds are shown as dashed lines, and bifurcations indicate the multiple possibilities for interaction partners.
(E, F) Side (E) and top (F) views of the b-helix structure showing the well-packed core and outward-pointing sidechains.
DOI: 10.1371/journal.pcbi.0010030.g001
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the turn-inducing amino acid sequence proline-glycine was
inserted at different sequence intervals—e.g., (Q9-PG-Q9)3
(PG-Q9) and (Q10-PG-Q10)3 (PG-Q10)—modulated the aggre-
gation kinetics of polyQ peptides. The mutant PG-Q9 was
found to aggregate at a marginally smaller rate than the wild-
type polyQ, and the critical nucleus size for aggregation, as
for the wild type, was one. The existence of nucleated
aggregation kinetics of the mutant suggests that, similar to
the wild type, barrier crossing from the ground state to an
aggregation-prone state occurs. Therefore, we hypothesized
that, similar to wild-type polyQ, a thermodynamically
unfavorable nucleating conformational transition occurs in
a single b-hairpin forming PGQ9 peptide. We studied the
conformational dynamics of the PGQ9-mutant peptide and
found that, in agreement with Thakur and Wetzel’s predic-
tion, this peptide forms a four-stranded antiparallel b-sheet.
The antiparallel structures are formed at low temperatures in
our simulation (Figure 3A and 3B). Do these mutants
aggregate through antiparallel b-hairpin structures or by
wild-type-like b-helix formation? Thakur and Wetzel’s data [5]
is compatible with either scenario. If b-hairpin formation is
rate-limiting (i.e., nucleates aggregation), since b-hairpin
formation by mutants is more thermodynamically favorable
than wild type, the aggregation rates of mutants should be
higher than wild type. In contrast, if wild type-like b-helix
formation in the mutants nucleates aggregation, their
aggregation rate compared to the wild type is expected to
be determined by the relative stabilities of the metastable
mutant and wild-type b-helices. To understand the nucleating
conformational transition in these mutant peptides, we
performed all-atom MD simulations of a PGQ9 sequence in
a b-helix conformation (Figure 3C). We found that, similar to
the wild type b-helix, the b-helix formed by PGQ9 remained
stable on the nanosecond time scale, but showed a greater
root mean-square distance (RMSD) compared to a wild type
b-helix of identical length (see Figure 2A). We compared the
RMSD per residue of the wild-type and mutant structures
(unpublished data) during MD simulations and found that the
destabilization induced by the proline-glycine is not limited
to the proline-glycine residues—it is transduced across the
whole peptide, leading to an overall higher RMSD. Thus, we
propose that the differential stability of the transiently
formed b-helix by the mutant peptide compared to wild-
type polyQ may underlie the experimentally observed slower
rate of aggregation of the mutant.
Mechanisms of protein aggregation [23] are increasingly
being sought as a framework for understanding and, impor-
tantly, therapeutically interfering with, the fundamental
events that underlie misfolding diseases [24]. The common
underlying basis of protein aggregation has been demonstra-
ted by the discovery of antibodies can cross-react with early
aggregatesof different peptides and proteins [25]. Further, the
early oligomers themselves, rather than the ﬁnal ﬁbrils, have
been shown to be toxic [26]. Thus, the conversion to speciﬁc b-
strand topologies is a common central feature associated with
cytotoxicity in all aggregation-linked diseases. The structural
basis of the mechanism of polyQ peptide aggregation that we
present here may thus aid the understanding and develop-
ment of rational therapies to modulate protein aggregation in
these debilitating neurodegenerative diseases.
Materials and Methods
We modeled the polyQ chain as ‘‘beads on a string,’’ where each
glutamine is represented by six pseudo-atoms—four corresponding
to the backbone NH, C9,C a, and O atoms, and two side chain atoms,
one for the methylene (-CH2-CH2-) groups and another for the
carboxylamine (-CONH2) group. Neighboring residues in this peptide
representation are covalently constrained to mimic the peptide
ﬂexibility in real proteins.
To study the conformational dynamics of polyQ, we introduce
simpliﬁed amino acid interactions: hydrophobic interactions be-
tween the methylene groups, polar interactions between sidechains
and backbone NH or O beads, and nonspeciﬁc backbone hydrogen
bonds as described in [16]. The interaction strengths of the hydro-
phobic interactions, sidechain-backbone polar interactions and
nonspeciﬁc backbone hydrogen bonds are assigned as 0.7e,5 e, and
5e, respectively. These interaction strengths were used to successfully
fold a miniprotein, the Trp-cage, to within 1 A ˚ of its native structure
[16]. Interactions in proline and glycine were also modeled as in [16].
We used the rapid DMD algorithm to perform simulations on our
model proteins [17,27,28].
We used the snapshots collected from DMD simulations to perform
all-atom MD simulations using standard MD protocols. Using a three-
step algorithm [29], we reconstructed all atoms of the polyQ chain
from the snapshots taken from simulations of coarse-grained protein
models. All-atom MD simulations were performed using the package
Figure 2. Formation and Stability of b-Helices
(A) RMSD versus time in all-atom MD simulations of polyQ peptide b-helices for wild-type b-helix (red) and PG-Q9 b-helix (black). The PG-Q9 b-helix was
constructed by replacing six glutamines in Q37 with the proline-glycine sequence inserted after every nine glutamines.
(B) The fraction of b-helix content as a function of temperature for a 25-mer (diamonds), 37-mer (unfilled circles), and 45-mer (squares). The fraction of b-
helix content was calculated by measuring the frequency of contacts between a residue i and residues i þ 16 to i þ 20, for all i.
DOI: 10.1371/journal.pcbi.0010030.g002
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A Molecular Basis of PolyQ AggregationAMBER 7, with the AMBER force-ﬁeld of parm99 [30,31] at a
temperature of 300 Kelvin and pressure of one atmosphere, in a
octahedral periodic box of water. The protocol for MD simulations
involved equilibration of the solvent and the peptide, and production
as described by Urbanc et al. [29]. The trajectory was recorded for 3
ns after equilibration.
Sidechain-backbone interactions have been identiﬁed as playing
important roles in the formation of protein structures. It has been
pointed out that the hydrogen bonds between the polar side chain
and backbones are important for the starting and ending of a-helices
[32,33] and for the formation of turns in proteins [34]. To evaluate
how sensitive our results were to the relative strengths of sidechain
and backbone hydrogen bonds, we performed DMD simulations with
varying relative strengths of sidechain and backbone hydrogen bonds
(esidechain/ebackbone). We found that for weaker sidechain hydrogen
bonds compared to backbone hydrogen bonds, i.e., esidechain/ebackbone
, 1, polyglutamine (polyQ) formed a-helices at low temperatures as
opposed to random coil structures observed at esidechain/ebackbone ¼ 1.
The observation of random coils at low temperatures is in agreement
with experiments in [35], and therefore we chose esidechain/ebackbone¼1.
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